Quest Diagnostics
medical research company
DGX NYSE
SEC CIK 1022079 LEI 8MCWUBXQ0WE04KMXBX50
Follow Quest Diagnostics
Weekly email: filings, results
Revenue, last quarter
$3.1B
+10% vs same quarter last year
Net income
$312M
+27.3% vs same quarter last year
EPS, diluted
$2.78
+28.7% vs same quarter last year
Operating cash flow
$611M
+8.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $11B | $992M |
| FY24 | $9.9B | $871M |
| FY23 | $9.3B | $854M |
| FY22 | $9.9B | $946M |
| FY21 | $10.8B | $2B |
| FY20 | $9.4B | $1.4B |
| FY19 | $7.7B | $858M |
| FY18 | $7.5B | $736M |
| FY17 | $7.4B | $772M |
| FY16 | $7.2B | $645M |
| FY15 | $7.5B | $709M |
| FY14 | $7.4B | $556M |
| FY13 | $7.1B | $849M |
| FY12 | $7.4B | $556M |
| FY11 | $7.4B | $471M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 33.2% | 14.1% | 9% |
| FY24 | 32.9% | 13.6% | 8.8% |
| FY23 | 33% | 13.6% | 9.2% |
| FY22 | 34.7% | 14.4% | 9.6% |
| FY21 | 39% | 22.1% | 18.5% |
| FY20 | 38.5% | 20.9% | 15.2% |
| FY19 | 34.8% | 15.9% | 11.1% |
| FY18 | 34.6% | 14.6% | 9.8% |
| FY17 | 36.2% | 15.7% | 10.4% |
| FY16 | 40.2% | 17.7% | 8.9% |
| FY15 | 37.8% | 18.7% | 9.5% |
| FY14 | 37.6% | 13.2% | 7.5% |
| FY13 | 39.5% | 20.6% | 11.9% |
| FY12 | 40.9% | 16.3% | 7.5% |
| FY11 | 41% | 13.4% | 6.4% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $1.4B |
| FY24 | $909M |
| FY23 | $864M |
| FY22 | $1.3B |
| FY21 | $1.8B |
| FY20 | $1.6B |
| FY19 | $843M |
| FY18 | $817M |
| FY17 | $923M |
| FY16 | $823M |
| FY15 | $558M |
| FY14 | $636M |
| FY13 | $421M |
| FY12 | $1B |
| FY11 | $734M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $353M | $450M |
| FY24 | $331M | $151M |
| FY23 | $314M | $275M |
| FY22 | $305M | $1.4B |
| FY21 | $309M | $2.2B |
| FY20 | $297M | $325M |
| FY19 | $286M | $353M |
| FY18 | $266M | $322M |
| FY17 | $247M | $465M |
| FY16 | $223M | $590M |
| FY15 | $212M | $224M |
| FY14 | $187M | $132M |
| FY13 | $185M | $1B |
| FY12 | $108M | $200M |
| FY11 | $65M | $935M |
- Quest Diagnostics
- Healthcare median
Show the numbers
| Year | Quest Diagnostics | Healthcare median |
|---|---|---|
| FY25 | 9% | −30.6% |
| FY24 | 8.8% | −47% |
| FY23 | 9.2% | −58% |
| FY22 | 9.6% | −80.4% |
| FY21 | 18.5% | −71.9% |
| FY20 | 15.2% | −62.2% |
| FY19 | 11.1% | −46.3% |
| FY18 | 9.8% | −49.6% |
| FY17 | 10.4% | −45.9% |
| FY16 | 8.9% | −36% |
| FY15 | 9.5% | −38.4% |
| FY14 | 7.5% | −35.5% |
| FY13 | 11.9% | −37.1% |
| FY12 | 7.5% | −29.1% |
| FY11 | 6.4% | −27.9% |